A01K 2227/106
Primate
A01K2227/106 (Primate) appears on 51 US grants and 118 published applications in this corpus.
Search patents in A01K- Granted patents
- 51
- Published applications
- 118
- Assignees
- 86
- Inventors
- 273
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 3 |
| 2003 | 0 | 5 |
| 2004 | 0 | 12 |
| 2005 | 1 | 7 |
| 2006 | 1 | 5 |
| 2007 | 3 | 9 |
| 2008 | 2 | 3 |
| 2009 | 1 | 7 |
| 2010 | 5 | 4 |
| 2011 | 3 | 4 |
| 2012 | 5 | 1 |
| 2013 | 2 | 7 |
| 2014 | 4 | 0 |
| 2015 | 2 | 6 |
| 2016 | 4 | 1 |
| 2017 | 0 | 2 |
| 2018 | 0 | 1 |
| 2019 | 0 | 4 |
| 2020 | 1 | 3 |
| 2021 | 3 | 9 |
| 2022 | 1 | 6 |
| 2023 | 2 | 2 |
| 2024 | 3 | 6 |
| 2025 | 2 | 8 |
| 2026 | 2 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Artificial expression constructs for selectively modulating gene expression in selected neuronal cell populations11 Aug 2026US 12,702,722 B2Allen Insitute
- Generation of a population of hindbrain cells and hindbrain-like organoids from pluripotent stem cells17 Mar 2026US 12,577,530 B2The J. David Gladstone Institutes, a testamentary trust established under the Will of J. David Gladstone
- Artificial expression constructs for selectively modulating gene expression in interneurons11 Nov 2025US 12,467,064 B2Allen Institute
- Compositions useful in treatment of metachromatic leukodystrophy24 Jun 2025US 12,338,451 B2
- Method for preparing non-human primate somatic cell cloned animal17 Sep 2024US 12,091,676 B2Center for Excellence In Brain Science and Intelligence Technology, Chinese Academy of Sciences
- Animal models, screening methods, and treatment methods for intraocular diseases or disorders24 Sep 2026US 2026/0283123 A1Smilebiotek Zhuhai Limited
- Animal models, screening methods, and treatment methods for intraocular diseases or disorders17 Sep 2026US 2026/0271895 A1Smilebiotek Zhuhai Limited
- Method for producing nonhuman primate animal model of cerebral infarction and pharmaceutical composition for treatment of cerebral infarction5 Mar 2026US 2026/0060221 A1Astellas Pharma Inc.
- Animal models and methods of use9 Oct 2025US 2025/0311706 A1Genentech, Inc.
- Compositions useful in treatment of metachromatic leukodystrophy9 Oct 2025US 2025/0313859 A1The Trustees of the University of Pennsylvania
Most cited
By later US patents
- Cloning using donor nuclei from proliferating somatic cells124US 5,945,577 AUniversity of Massachusetts as represented by its Amherst Campus · 1999
- CICM cells and non-human mammalian embryos prepared by nuclear transfer of a proliferating differentiated cell or its nucleus45US 6,235,970 B1University of Massachusetts, Amherst Campus · 2001
- Assay utilizing multipotent adult stem cells39US 7,838,289 B2ABT Holding Company · 2010
- Therapeuting compositions comprising an RNAi agent and a neurotrophic factor and methods of use thereof23US 8,183,219 B2Medtronic, Inc. · 2012
- Calcitonin gene related peptide receptor antagonists11US 7,220,862 B2Bristol-Myers Squibb Company · 2007